Passion and purpose to transform patient journeys in anxiety and depression.

About Us

Redefining What’s Possible for Millions Struggling with Anxiety and Depression

Faster. Safer. Better. These outcomes are the clarion calls of millions of people in the U.S. and around the world seeking better treatments for anxiety and depression. At Vistagen, we know that patients are searching for bold changes to improve their lives. We are on a mission — a mission to radically change the trajectory of mental health care through our distinct therapeutic approaches – One Mind at a TimeTM.

Our Leadership

Our executive team is made up of visionary thinkers and experts, dedicated to positioning Vistagen for long-term success.

Reid Adler, J.D.

Chief Corporate Development Officer and General Counsel

Ross A. Baker, Ph.D., MBA,

Vice President, Medical Strategy

Erik Berglund, M.D., Ph.D., R.A.C.

Senior Vice President, Global Regulatory Affairs & Pharmacovigilance

Allen (Jo) Cato, III Ph.D.

Senior Vice President, Development Operations

Rita E. Hanover, Ph.D., R.A.C.

Vice President, Biostatistics and Clinical Analytics

Jessica R. Haskell J.D.

Vice President, Associate General Counsel and Secretary

Mark A. McPartland

Senior Vice President, Investor Relations

Louis Monti, M.D., Ph.D.

Vice President, Translational Medicine

Scroll to top